Keyphrases
Chronic Spinal Cord Injury
100%
Knee
100%
Bone Mineral
100%
Romosozumab
100%
Spinal Cord Injury
33%
Bone Loss
33%
Antiresorptive
33%
Monoclonal Antibody
16%
Acute Phase
16%
Female Participants
16%
Finite Element Analysis
16%
Treatment Impact
16%
Osteoporosis
16%
Fracture Risk
16%
Computed Tomography
16%
Bone Strength
16%
Anabolic Effect
16%
Cortical Bone
16%
Subcutaneous Injection
16%
Finite Element
16%
Pharmaceutical Intervention
16%
Lumbar Spine
16%
Total Hip
16%
Ambulate
16%
Proximal Tibia
16%
Neurological Lesion
16%
Bone Properties
16%
Distal Femur
16%
DXA Scan
16%
Longitudinal Mixed Model
16%
Mineral Analysis
16%
Immunology and Microbiology
Spinal Cord
100%
Knee
100%
Hip
100%
Bone Mineral
100%
Romosozumab
100%
Osteolysis
28%
Monoclonal Antibody
14%
Cortical Bone
14%
Lumbar Spine
14%
Bone Strength
14%
X-Ray Computed Tomography
14%
Distal Femur
14%
Proximal Tibia
14%
Medicine and Dentistry
Spinal Cord Injury
100%
Bone Mineral
100%
Romosozumab
100%
Finite Element Analysis
28%
Dual-Energy X-Ray Absorptiometry
28%
Osteolysis
28%
Lumbar Spine
14%
Subcutaneous Injection
14%
Cortical Bone
14%
Proximal Tibia
14%
Distal Femur
14%
Osteoporosis
14%
Bone Strength
14%
Monoclonal Antibody
14%
Nursing and Health Professions
Spinal Cord Injury
100%
Romosozumab
100%
Finite Element Analysis
28%
Subcutaneous Injection
14%
Bone Strength
14%
Monoclonal Antibody
14%
X-Ray Computed Tomography
14%
Pharmacology, Toxicology and Pharmaceutical Science
Spinal Cord Injury
100%
Romosozumab
100%
Monoclonal Antibody
14%
Subcutaneous Injection
14%